WallStSmart

CBIZ Inc (CBZ)vsRelx PLC ADR (RELX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Relx PLC ADR generates 248% more annual revenue ($9.59B vs $2.76B). RELX leads profitability with a 21.5% profit margin vs 4.2%. RELX appears more attractively valued with a PEG of 1.36. RELX earns a higher WallStSmart Score of 62/100 (C+).

CBZ

Buy

55

out of 100

Grade: C

Growth: 6.7Profit: 4.0Value: 7.3Quality: 5.3
Piotroski: 3/9Altman Z: 1.53

RELX

Buy

62

out of 100

Grade: C+

Growth: 5.3Profit: 9.0Value: 10.0Quality: 3.8
Piotroski: 4/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CBZSignificantly Overvalued (-144.9%)

Margin of Safety

-144.9%

Fair Value

$12.44

Current Price

$25.59

$13.15 premium

UndervaluedFair: $12.44Overvalued
RELXUndervalued (+43.1%)

Margin of Safety

+43.1%

Fair Value

$50.66

Current Price

$32.47

$18.19 discount

UndervaluedFair: $50.66Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CBZ3 strengths · Avg: 8.7/10
Price/BookValuation
0.8x10/10

Reasonable price relative to book value

P/E RatioValuation
14.0x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
17.9%8/10

17.9% revenue growth

RELX5 strengths · Avg: 9.2/10
Return on EquityProfitability
70.5%10/10

Every $100 of equity generates 71 in profit

Operating MarginProfitability
31.4%10/10

Strong operational efficiency at 31.4%

Market CapQuality
$60.80B9/10

Large-cap with strong market position

Profit MarginProfitability
21.5%9/10

Keeps 22 of every $100 in revenue as profit

Free Cash FlowQuality
$1.48B8/10

Generating 1.5B in free cash flow

Areas to Watch

CBZ4 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.534/10

Distress zone — elevated risk

Market CapQuality
$1.41B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
6.5%3/10

ROE of 6.5% — below average capital efficiency

Profit MarginProfitability
4.2%3/10

4.2% margin — thin

RELX3 concerns · Avg: 3.0/10
Price/BookValuation
18.8x4/10

Trading at 18.8x book value

Revenue GrowthGrowth
1.2%4/10

1.2% revenue growth

Debt/EquityHealth
3.101/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : CBZ

The strongest argument for CBZ centers on Price/Book, P/E Ratio, Revenue Growth. Revenue growth of 17.9% demonstrates continued momentum. PEG of 1.46 suggests the stock is reasonably priced for its growth.

Bull Case : RELX

The strongest argument for RELX centers on Return on Equity, Operating Margin, Market Cap. Profitability is solid with margins at 21.5% and operating margin at 31.4%. PEG of 1.36 suggests the stock is reasonably priced for its growth.

Bear Case : CBZ

The primary concerns for CBZ are Altman Z-Score, Market Cap, Return on Equity. Thin 4.2% margins leave little buffer for downturns.

Bear Case : RELX

The primary concerns for RELX are Price/Book, Revenue Growth, Debt/Equity. Debt-to-equity of 3.10 is elevated, increasing financial risk.

Key Dynamics to Monitor

CBZ profiles as a growth stock while RELX is a value play — different risk/reward profiles.

CBZ carries more volatility with a beta of 0.93 — expect wider price swings.

CBZ is growing revenue faster at 17.9% — sustainability is the question.

RELX generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

RELX scores higher overall (62/100 vs 55/100), backed by strong 21.5% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CBIZ Inc

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

CBIZ, Inc. provides financial, insurance and advisory services in the United States and Canada. The company is headquartered in Cleveland, Ohio.

Relx PLC ADR

INDUSTRIALS · SPECIALTY BUSINESS SERVICES · USA

RELX PLC provides information-based decision-making and analysis tools for professional and commercial clients in North America, Europe, and internationally. The company is headquartered in London, the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?